$822 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 62 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 105.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Buy | SPDR S&P 500 ETF TRput | $115,868,000 | +54.7% | 270,000 | +54.3% | 14.10% | +62.4% |
| IWM | New | ISHARES TRput | $95,156,000 | – | 435,000 | +100.0% | 11.58% | – |
| FB | Buy | FACEBOOK INCcl a | $41,937,000 | +2.9% | 123,567 | +5.4% | 5.10% | +8.1% |
| RAPT | Buy | RAPT THERAPEUTICS INC | $35,655,000 | +45.5% | 1,148,321 | +49.0% | 4.34% | +52.8% |
| APG | Buy | API GROUP CORP | $27,730,000 | +7.3% | 1,362,656 | +10.1% | 3.37% | +12.6% |
| XBI | Buy | SPDR SER TRput | $23,256,000 | +2.8% | 185,000 | +10.8% | 2.83% | +8.0% |
| UAA | New | UNDER ARMOUR INCcl a | $20,180,000 | – | 1,000,000 | +100.0% | 2.46% | – |
| FOUR | Buy | SHIFT4 PMTS INCcl a | $18,013,000 | +60.3% | 232,370 | +93.9% | 2.19% | +68.3% |
| DIS | Buy | DISNEY WALT CO | $17,915,000 | +6.3% | 105,900 | +10.4% | 2.18% | +11.6% |
| AVY | New | AVERY DENNISON CORP | $16,504,000 | – | 79,650 | +100.0% | 2.01% | – |
| SBNY | Buy | SIGNATURE BK NEW YORK N Y | $15,180,000 | +20.1% | 55,750 | +8.4% | 1.85% | +26.2% |
| TNDM | New | TANDEM DIABETES CARE INC | $13,251,000 | – | 111,000 | +100.0% | 1.61% | – |
| HUM | New | HUMANA INC | $13,153,000 | – | 33,800 | +100.0% | 1.60% | – |
| PAGS | Buy | PAGSEGURO DIGITAL LTD | $12,591,000 | -6.2% | 243,450 | +1.4% | 1.53% | -1.5% |
| GNRC | New | GENERAC HLDGS INC | $12,260,000 | – | 30,000 | +100.0% | 1.49% | – |
| WSC | Buy | WILLSCOT MOBIL MINI HLDNG CO | $12,233,000 | +25.2% | 385,670 | +10.0% | 1.49% | +31.4% |
| CARA | Buy | CARA THERAPEUTICS INC | $11,057,000 | +79.3% | 715,684 | +65.6% | 1.34% | +88.1% |
| TWLO | Buy | TWILIO INCcl a | $10,635,000 | +27.2% | 33,334 | +57.2% | 1.29% | +33.7% |
| CRIS | Buy | CURIS INC | $10,016,000 | +1.0% | 1,279,220 | +4.1% | 1.22% | +6.1% |
| EQH | New | EQUITABLE HLDGS INC | $9,900,000 | – | 334,000 | +100.0% | 1.20% | – |
| SE | Buy | SEA LTDsponsord ads | $9,881,000 | +26.5% | 31,000 | +9.0% | 1.20% | +32.8% |
| ROP | New | ROPER TECHNOLOGIES INC | $9,213,000 | – | 20,650 | +100.0% | 1.12% | – |
| XAIR | Buy | BEYOND AIR INC | $8,676,000 | +92.6% | 780,228 | +12.2% | 1.06% | +102.3% |
| PRAX | Buy | PRAXIS PRECISION MEDICINES I | $7,664,000 | +67.7% | 414,489 | +65.8% | 0.93% | +75.8% |
| HAE | New | HAEMONETICS CORP MASS | $7,059,000 | – | 100,000 | +100.0% | 0.86% | – |
| HAE | New | HAEMONETICS CORP MASSput | $7,059,000 | – | 100,000 | +100.0% | 0.86% | – |
| New | SOVOS BRANDS INC | $7,045,000 | – | 505,000 | +100.0% | 0.86% | – | |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $6,853,000 | -13.4% | 1,021,317 | +1.0% | 0.83% | -9.1% |
| GSAH | New | GS ACQUISITION HLDGS CORP II | $6,725,000 | – | 658,000 | +100.0% | 0.82% | – |
| VINC | Buy | VINCERX PHARMA INC | $4,930,000 | +86.6% | 304,896 | +49.9% | 0.60% | +96.1% |
| EDIT | New | EDITAS MEDICINE INCput | $4,108,000 | – | 100,000 | +100.0% | 0.50% | – |
| New | IMAGO BIOSCIENCES INC | $3,482,000 | – | 173,830 | +100.0% | 0.42% | – | |
| APLS | New | APELLIS PHARMACEUTICALS INC | $3,296,000 | – | 100,000 | +100.0% | 0.40% | – |
| FHTX | New | FOGHORN THERAPEUTICS INC | $2,866,000 | – | 205,741 | +100.0% | 0.35% | – |
| FVRR | New | FIVERR INTL LTDput | $1,827,000 | – | 10,000 | +100.0% | 0.22% | – |
| NEXI | New | NEXIMMUNE INC | $1,786,000 | – | 117,962 | +100.0% | 0.22% | – |
| APLS | New | APELLIS PHARMACEUTICALS INCput | $1,648,000 | – | 50,000 | +100.0% | 0.20% | – |
| ACET | Buy | ADICET BIO INC | $1,098,000 | -7.2% | 140,000 | +21.7% | 0.13% | -2.2% |
| New | GINKGO BIOWORKS HOLDINGS INC | $869,000 | – | 75,000 | +100.0% | 0.11% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
| SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
| ISHARES TR | 27 | Q3 2023 | 13.2% |
| HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
| SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
| META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
| LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
| NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
| AMAZON COM INC | 18 | Q3 2022 | 7.6% |
| SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
| GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
| Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
| Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
| Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
| AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
| FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
| Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
| Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-15 |
| 13F-HR/A | 2024-03-18 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2023-11-29 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-13 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.